You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,130,640


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,130,640 protect, and when does it expire?

Patent 10,130,640 protects ENSTILAR and is included in one NDA.

Protection for ENSTILAR has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has thirty-six patent family members in twenty-five countries.

Summary for Patent: 10,130,640
Title:Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid
Abstract: The present invention relates to a topical spray composition comprising a biologically active vitamin D derivative or analog and a corticosteroid, and its use in the treatment of dermal diseases and conditions.
Inventor(s): Lind; Marianne (Bagsv.ae butted.rd, DK), Rasmussen; Gritt (Virum, DK), Sonne; Mette Rydahl (Brondby Strand, DK), Hansen; Jens (Virum, DK), Petersson; Karsten (Ballerup, DK)
Assignee: Leo Pharma A/S (Ballerup, DK)
Application Number:14/707,733
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 10,130,640
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,130,640: A Detailed Analysis

Introduction

Patent 10,130,640, like any other patent, is a complex document that outlines the scope, claims, and innovations of a particular invention. To fully comprehend its significance, it is crucial to delve into the specifics of the patent, including its claims, the patent landscape, and the relevant legal frameworks.

Patent Overview

Invention Description

United States Patent 10,130,640 typically describes an invention in detail, including its components, functionality, and the problems it solves. This description is critical for understanding the scope of the invention and how it differs from prior art.

Claims Analysis

Types of Claims

Patent claims are the heart of any patent application, defining the scope of protection sought by the inventor. There are two main types of claims: independent claims and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[4].

Claim Construction

The construction of claims is pivotal in determining the patentability and scope of the invention. Claims must be clear, concise, and definite to avoid rejections under 35 U.S.C. § 112(b)[2].

Patent Eligibility Under Section 101

Abstract Ideas and Judicial Exceptions

Section 101 of the U.S. Patent Act governs what types of inventions are eligible for patent protection. Abstract ideas, laws of nature, and natural phenomena are not patentable. However, if an abstract idea is integrated into a practical application, it may become patent-eligible[4].

Recent Guidance and Case Law

The 2024 USPTO guidance update on AI patents emphasizes the importance of integrating judicial exceptions into practical applications. For example, if a claim merely uses a mathematical model without applying it in a specific manner, it is not patent-eligible. However, if the claim specifies a practical application, such as using separated audio components in a speech recognition system, it can meet the criteria for patent eligibility[1].

Patent Landscape and Prior Art

Relevance of Prior Art

Prior art plays a crucial role in determining the novelty and non-obviousness of an invention. The patent landscape must be thoroughly searched to ensure that the claimed invention is not anticipated by existing patents or publications.

Reissue Claims and Original Patent Requirement

For reissue patents, the claims must be directed to the invention disclosed in the original patent. This requirement ensures that the reissue claims do not cover a different invention than what was originally disclosed[2].

Economic and Statistical Insights

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset provides valuable insights into patent claims and their scope. This dataset can help in understanding trends and patterns in patent claims, which can be useful for drafting and evaluating patent applications[3].

Case Law and Judicial Precedents

Diamond v. Diehr and Parker v. Flook

Key cases like Diamond v. Diehr and Parker v. Flook have shaped the landscape of patent eligibility. In Diamond v. Diehr, the Supreme Court held that a process using a computer to control heating times in a rubber curing process was patentable because it was a practical application rather than just a mathematical algorithm. In contrast, Parker v. Flook found that a method for updating an alarm limit was unpatentable because it did not add any patentable invention beyond the algorithm itself[4].

Drafting Patent-Eligible Claims

Practical Applications and Real-World Benefits

To draft patent-eligible claims, it is essential to highlight the real-world applications and practical benefits of the invention. Claims should demonstrate how the abstract idea is transformed into a specific, practical application that provides concrete benefits[1].

Avoiding Routine Data Processing

Claims should avoid routine data processing steps that do not transform the abstract idea into a patent-eligible invention. Instead, they should include additional steps that provide tangible outcomes and directly benefit the technology[1].

Industry Expert Insights

Industry experts emphasize the importance of understanding the legal and technical nuances of patent claims. For instance, "By specifying the use of the separated audio components in a real-time speech recognition system to enhance the accuracy of voice commands in hands-free environments, the claim adds a level of practical utility that is not present in mere data processing steps," notes a patent practitioner[1].

Illustrative Statistics

The USPTO's Patent Claims Research Dataset reveals that between 1976 and 2014, there was a significant increase in the number of patent claims related to software and AI technologies. This trend underscores the growing importance of carefully crafting patent claims to ensure eligibility[3].

Real-World Applications

Example: AI in Speech Recognition

The practical application of AI in speech recognition systems is a compelling example. By integrating AI into a speech recognition system, the invention can improve the accuracy of voice commands, providing a tangible benefit that meets the criteria for patent eligibility[1].

Challenges and Opportunities

Navigating Section 101 Rejections

One of the significant challenges in patenting AI-related inventions is navigating Section 101 rejections. However, by focusing on the practical applications and real-world benefits of the invention, innovators can overcome these challenges and secure patent protection[1].

Leveraging AI as a Tool

The 2024 USPTO guidance update clarifies that AI-assisted inventions are evaluated on equal footing with other technologies, provided there is significant human contribution. This distinction opens up opportunities for innovators to leverage AI as a tool to develop patent-eligible inventions[1].

Key Takeaways

  • Patent Eligibility: Ensure that claims integrate judicial exceptions into practical applications to meet Section 101 requirements.
  • Practical Applications: Highlight real-world applications and tangible benefits of the invention.
  • Avoid Routine Data Processing: Claims should go beyond mere data processing steps to provide concrete technological improvements.
  • AI-Assisted Inventions: AI’s role as a tool does not exclude inventions from eligibility, provided there is significant human contribution.
  • Reissue Claims: Reissue claims must be directed to the invention disclosed in the original patent.

Frequently Asked Questions (FAQs)

1. What is the significance of the 2024 USPTO guidance update on AI patents?

The 2024 USPTO guidance update refines and clarifies the process for determining the patent eligibility of AI-related inventions, providing examples and detailed eligibility analysis to aid practitioners in drafting patent-eligible claims.

2. How do you ensure that a claim is patent-eligible under Section 101?

To ensure patent eligibility, claims must integrate judicial exceptions into practical applications, demonstrating real-world benefits and tangible technological improvements.

3. Can AI-assisted inventions be patented?

Yes, AI-assisted inventions can be patented if they are evaluated on equal footing with other technologies and there is significant human contribution to the claimed invention.

4. What are the requirements for reissue claims under 35 U.S.C. § 251?

Reissue claims must be directed to the invention disclosed in the original patent, ensuring that the reissue claims do not cover a different invention than what was originally disclosed.

5. How can the USPTO's Patent Claims Research Dataset help in patent drafting?

The dataset provides valuable insights into trends and patterns in patent claims, helping practitioners understand how to draft claims that are more likely to meet patent eligibility criteria.

Cited Sources:

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. In Re FLOAT'N'GRILL LLC - Court of Appeals for the Federal Circuit
  3. Patent Claims Research Dataset - USPTO
  4. Section 101 Subject Matter Eligibility Index - BitLaw

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,130,640

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Leo Pharma As ENSTILAR betamethasone dipropionate; calcipotriene AEROSOL, FOAM;TOPICAL 207589-001 Oct 16, 2015 AB RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,130,640

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2011264198 ⤷  Subscribe
Brazil 112012030653 ⤷  Subscribe
Canada 2800181 ⤷  Subscribe
China 102939078 ⤷  Subscribe
Cyprus 1115991 ⤷  Subscribe
Denmark 2579852 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.